View in EDS HTML Full Text PDF Full Text

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Authors: Nassar AH; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT, 06510, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Abou Alaiwi S; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Baca SC; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Adib E; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Corona RI; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Fonseca MAS; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., El Zarif T; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tisza V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Braun DA; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT, 06510, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Du H; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA., He M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Flaifel A; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Alchoueiry M; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA., Denize T; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Matar SG; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Acosta A; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Shukla S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Hou Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Steinharter J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Bouchard G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Berchuck JE; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., O'Connor E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Mary Lee GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA., Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Henske E; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; McGraw/Patterson Center for Population Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Lawrenson K; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Choueiri TK; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. toni_choueiri@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. toni_choueiri@dfci.harvard.edu., Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. dk@rics.bwh.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. dk@rics.bwh.harvard.edu., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. mfreedman@partners.org.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. mfreedman@partners.org.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA. mfreedman@partners.org.
Source: Nature communications [Nat Commun] 2023 Jan 21; Vol. 14 (1), pp. 346. Date of Electronic Publication: 2023 Jan 21.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36681680
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nassar+AH%22">Nassar AH</searchLink>; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT, 06510, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Abou+Alaiwi+S%22">Abou Alaiwi S</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Baca+SC%22">Baca SC</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Adib+E%22">Adib E</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Corona+RI%22">Corona RI</searchLink>; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Seo+JH%22">Seo JH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Fonseca+MAS%22">Fonseca MAS</searchLink>; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Spisak+S%22">Spisak S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22El+Zarif+T%22">El Zarif T</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Tisza+V%22">Tisza V</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Braun+DA%22">Braun DA</searchLink>; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT, 06510, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA.<br /><searchLink fieldCode="AU" term="%22Du+H%22">Du H</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22He+M%22">He M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Flaifel+A%22">Flaifel A</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Alchoueiry+M%22">Alchoueiry M</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Denize+T%22">Denize T</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Matar+SG%22">Matar SG</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Acosta+A%22">Acosta A</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Shukla+S%22">Shukla S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hou+Y%22">Hou Y</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Steinharter+J%22">Steinharter J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Bouchard+G%22">Bouchard G</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Berchuck+JE%22">Berchuck JE</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22O'Connor+E%22">O'Connor E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Bell+C%22">Bell C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Nuzzo+PV%22">Nuzzo PV</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Mary+Lee+GS%22">Mary Lee GS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Signoretti+S%22">Signoretti S</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Hirsch+MS%22">Hirsch MS</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Pomerantz+M%22">Pomerantz M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Henske+E%22">Henske E</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Gusev+A%22">Gusev A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; McGraw/Patterson Center for Population Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Lawrenson+K%22">Lawrenson K</searchLink>; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. toni_choueiri@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. toni_choueiri@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Kwiatkowski+DJ%22">Kwiatkowski DJ</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. dk@rics.bwh.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. dk@rics.bwh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Freedman+ML%22">Freedman ML</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. mfreedman@partners.org.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. mfreedman@partners.org.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA. mfreedman@partners.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Jan 21; Vol. 14 (1), pp. 346. <i>Date of Electronic Publication: </i>2023 Jan 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36681680
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-023-35833-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 346
    Titles:
      – TitleFull: Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nassar AH
      – PersonEntity:
          Name:
            NameFull: Abou Alaiwi S
      – PersonEntity:
          Name:
            NameFull: Baca SC
      – PersonEntity:
          Name:
            NameFull: Adib E
      – PersonEntity:
          Name:
            NameFull: Corona RI
      – PersonEntity:
          Name:
            NameFull: Seo JH
      – PersonEntity:
          Name:
            NameFull: Fonseca MAS
      – PersonEntity:
          Name:
            NameFull: Spisak S
      – PersonEntity:
          Name:
            NameFull: El Zarif T
      – PersonEntity:
          Name:
            NameFull: Tisza V
      – PersonEntity:
          Name:
            NameFull: Braun DA
      – PersonEntity:
          Name:
            NameFull: Du H
      – PersonEntity:
          Name:
            NameFull: He M
      – PersonEntity:
          Name:
            NameFull: Flaifel A
      – PersonEntity:
          Name:
            NameFull: Alchoueiry M
      – PersonEntity:
          Name:
            NameFull: Denize T
      – PersonEntity:
          Name:
            NameFull: Matar SG
      – PersonEntity:
          Name:
            NameFull: Acosta A
      – PersonEntity:
          Name:
            NameFull: Shukla S
      – PersonEntity:
          Name:
            NameFull: Hou Y
      – PersonEntity:
          Name:
            NameFull: Steinharter J
      – PersonEntity:
          Name:
            NameFull: Bouchard G
      – PersonEntity:
          Name:
            NameFull: Berchuck JE
      – PersonEntity:
          Name:
            NameFull: O'Connor E
      – PersonEntity:
          Name:
            NameFull: Bell C
      – PersonEntity:
          Name:
            NameFull: Nuzzo PV
      – PersonEntity:
          Name:
            NameFull: Mary Lee GS
      – PersonEntity:
          Name:
            NameFull: Signoretti S
      – PersonEntity:
          Name:
            NameFull: Hirsch MS
      – PersonEntity:
          Name:
            NameFull: Pomerantz M
      – PersonEntity:
          Name:
            NameFull: Henske E
      – PersonEntity:
          Name:
            NameFull: Gusev A
      – PersonEntity:
          Name:
            NameFull: Lawrenson K
      – PersonEntity:
          Name:
            NameFull: Choueiri TK
      – PersonEntity:
          Name:
            NameFull: Kwiatkowski DJ
      – PersonEntity:
          Name:
            NameFull: Freedman ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 01
              Text: 2023 Jan 21
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1